drugset / Trial / NCT02174237
A Study to Test the Safety/Tolerability of Increasing Doses of LNP1892 Versus Placebo in Healthy Male/Female Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple ascending oral dose LNP1892 in healthy males and female subjects
Timeline
- Start
- 2014-05
- Primary completion
- 2014-09
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LNP1892 | Small molecule | 5 mg | Oral |
| Subject | LNP1892 | Small molecule | 25 mg | Oral |
Indications
No indication recorded.